Table 4.
Complications and adverse events | Surgery | Studies (n) | P value | Incidence | ||
---|---|---|---|---|---|---|
Odds ratio (95% CI) | Heterogeneity (I 2) | Model | ||||
Infection | TKA THA |
6 5 |
0.69 - |
1.51 [0.19, 11.84] - |
0% - |
Fixed - |
Delayed wound healing | TKA THA |
6 5 |
0.66 - |
1.50 [0.25, 9.12] - |
0% - |
Fixed - |
ONFH | TKA THA |
1 2 |
- - |
- - |
- - |
- - |
VTE | TKA THA |
4 2 |
- - |
- - |
- - |
- - |
Pruritus | TKA THA |
3 2 |
0.56 0.65 |
1.41 [0.44, 4.49] 1.53 [0.24, 9.59] |
0% 0% |
Fixed Fixed |
Serum glucose | TKA THA |
4 2 |
0.001 0.007 |
22.56 mg/dl [16.9, 28.23]* 29.45 mg/dl [8.06, 50.84]* |
0% 0% |
Fixed Fixed |
ONFH osteonecrosis of femoral head, VTE venous thromboembolic events
-Not occurring, unable to statistically analyze
*Were meta-analyzed in terms of the weighted mean difference (WMD)